Preface

Prompt diagnosis and early intervention are now recognized as an essential factor in survival of critical illness. This is certainly true for both sepsis and acute respiratory distress syndrome, the two most common disease states with which we are faced in critical care. We last edited an issue of Critical Care Clinics on “Biomarkers in the Critically Ill Patient” in 2011. It would be great if I were able to report that, over the past 9 to 10 years, we have made remarkable progress in the field and can now use biomarkers for early diagnosis, precision targeting for guiding the use of new therapeutic agents, inclu sion criteria in large randomized controlled trials, or to determine specific risk profiles that facilitate clinical decision making in the emergency department and the medical wards.
Source: Critical Care Clinics - Category: Intensive Care Authors: Source Type: research